Global Trial

LEADERS

Overview

For the past decade, Gibson, Dunn & Crutcher has been recognized as the best litigation firm in the country.  Acclaimed as a litigation powerhouse, Gibson Dunn has a long record of outstanding successes at trial.  By way of example, The American Lawyer named Gibson Dunn a Finalist in its 2022 Litigation Department of the Year competition, noting that “when news breaks and the pressure rises, clients call Gibson Dunn’s litigators to regain control.”  This award follows our unprecedented four wins in this biennial competition. The New York Law Journal named Gibson Dunn the General Litigation Winner in its 2020 Litigation Departments of the Year contest.  Additionally, our lawyers frequently are recognized as “Litigators of the Week.”  Chambers USA also named Gibson Dunn its “Commercial Litigation Law Firm of the Year” at its 2021 Chambers USA Awards, noting that “Gibson Dunn stands out as the ‘absolute all stars’ of the field, offering premier litigators from coast to coast and a glowing reputation as ‘an excellent all-around law firm with a very deep bench.’”

The members of Gibson Dunn’s Global Trial Practice are not just litigators, they are first-rate trial lawyers.  Each year, our lawyers try numerous cases to verdict before juries, judges, arbitrators and administrative agencies.  Our clients have trusted us to try their most significant disputes to verdict, and we have a proven track record of success across a wide variety of matters.  We have tried cases in federal and state courts across the United States involving almost every foreseeable area of controversy.  We also handle disputes before a wide variety of nonjudicial forums, from federal and state agencies to international arbitrations.

Gibson Dunn’s trial practice has been recognized repeatedly in the legal press.  Law360 named Gibson Dunn one of its five Trials Groups of the Year for 2020, recognized in part for its wins for “AMC in a case against producers of ‘The Walking Dead’ who want more of the show’s profits” and for “Novartis in beating back an intellectual property challenge to a multiple sclerosis drug.”

Benchmark Litigation US named four partners to its 2022 “Top 100 Trial Lawyers in America” list: Dallas partner Veronica Moyé, New York partners Randy Mastro and Orin Snyder, and Washington, D.C. partner Richard Parker.  The same publication also recognized Gibson Dunn in eight U.S. litigation practice areas and named the firm as one of the “Top 20 Trial Firms” in the United States, in addition to ranking the firm Tier 1 in the United States for its Antitrust, Appellate, General Commercial, Intellectual Property, Labor & Employment, Securities and White Collar Crime practices.

EXPERIENCE & RECENT REPRESENTATIONS

Representative high-profile trial achievements by Gibson Dunn lawyers in the past several years include:

  • Achieved a unanimous jury verdict for Hewlett-Packard Co. (HP) after a three-week bench trial on contract interpretation and a five-week jury trial on breach and damages in the California Superior Court, which resulted in an award to HP of more than $3 billion against Oracle Corporation. This was one of the largest single-plaintiff jury verdicts in U.S. history, and the verdict, valued at more than $4.5 billion with post-judgment interest, was later affirmed by the California Court of Appeal.  The affirmance marked the culmination of ten years of litigation following Oracle’s decision in 2011 to cease offering new versions of its software products to customers running HP’s high-end Itanium servers, which HP argued breached a contract between the parties.  The Daily Journal named the jury verdict, the highest verdict in California for the year, as one of its Top Plaintiffs’ Verdicts by Dollar.
  • Obtained a sweeping bench trial victory for AMC Network in a high-stakes lawsuit in the California Superior Court brought by executive producers on the hit television show “The Walking Dead.” The plaintiffs alleged that the network failed to pay them hundreds of millions of dollars under their “profit participation” contracts with AMC.  The Court agreed with AMC, holding that the plaintiffs’ interpretation of their profit participation contracts was completely incorrect.  The Hollywood Reporter remarked that AMC’s “huge” win has the potential “to impact Hollywood dealmaking” and shape profit participation negotiations throughout the industry.  The case was named among the “Top 20 Defense Results” of 2020 by the Daily Journal.
  • Twice secured the largest defense victory in a patent infringement suit in history for EMD Serono, Inc. (the biopharmaceutical business of Merck KGaA in the U.S. and Canada) and Pfizer Inc., first with a unanimous jury verdict in a five-week trial in the District of New Jersey and later in a unanimous Federal Circuit decision.  Plaintiff Biogen sought more than $5.4 billion in damages – more than double the largest award in patent litigation history – for alleged infringement of its patent in connection with the marketing and sale of the multiple sclerosis medicine Rebif®.  The Federal Circuit reinstated the jury’s verdict that the asserted claims of Biogen’s patent were invalid, thereby reversing the district court’s post-trial order that had granted Biogen judgment as a matter of law and a conditional new trial.  The U.S. Supreme Court denied Biogen’s petition for certiorari, conclusively ending more than a decade of litigation. Gibson Dunn’s win was named a “Patent Impact Case of the Year” at the LMG Life Sciences Awards.
  • Secured a complete trial victory for Fitbit in a high-profile, high-stakes patent case brought by Philips against Fitbit and Garmin in the International Trade Commission.  The plaintiff had asserted patent claims against virtually all of Fitbit’s smartwatch and tracker products, and sought an exclusion order to stop Fitbit from importing or selling the products anywhere in the United States for the life of the patents.  The ITC rejected these claims as invalid or not infringed, and rejected the plaintiff’s request to exclude Fitbit’s products from the United States. The Am Law Litigation Daily recognized the trial team with its “Litigator of the Week” award for its success.
  • Won a high-profile defense jury verdict following a three-week trial for Textron Financial in the Northern District of Ohio, completely defeating a bankruptcy trustee’s billion-dollar fraudulent transfer claim. The plaintiff had alleged Textron’s involvement in a notorious “Ponzi scheme” fraud at an Ohio company, Fair Finance, whose executives bilked thousands of investors of their life savings and, as a result, went to jail for their crimes.  The trustee appealed the verdict, arguing that the district court mistakenly rejected its arguments at summary judgment and erroneously instructed the jury at trial.  The U.S. Court of Appeals for the Sixth Circuit rejected the trustee’s arguments, affirming the verdict in favor of Textron Financial and ending more than nine years of hard-fought litigation.  For its victory, Gibson Dunn’s trial team received The Am Law Litigation Daily “Litigator of the Week” honor and were recognized as “Masters of the Courtroom” in The National Law Journal Winning Litigators report.
  • Secured a landmark ruling on behalf of Deutsche Telekom, following a two-week trial in the Southern District of New York, which held that Deutsche Telekom’s entity’s $26.5 billion acquisition of Sprint Corporation did not violate Clayton Act §7, thereby clearing the way for the acquisition to proceed.
  • Defeated challenges to Novartis Pharmaceuticals Corporation’s patent covering Gilenya®, its blockbuster multiple sclerosis drug with $2 billion in annual global sales, following a four-day bench trial in the District of Delaware. Generic drug makers had challenged the patent in an IPR proceeding, but Gibson Dunn persuaded the Patent Office to reject the challenges.  Gibson Dunn then filed suit against 23 generic drug makers and, with expiration of Novartis’s compound patent fast approaching and the normal 30-month stay of FDA approval unavailable, won a preliminary injunction to maintain exclusivity.  Litigation continued and one generic drug maker, HEC Pharma, finally remained in the case for the trial.  The court rejected all challenges to the patent.  Law360 featured this win, among others, in naming Gibson Dunn as one of its five Trials Groups of the Year for 2020.
  • Defeated class claims for more than $415 million in a first-of-its-kind ramen noodle-related antitrust price-fixing case for Ottogi Corporation, Ltd. and Ottogi America, Inc. following a five-week trial in the Northern District of California. The long-running case, brought by classes of both direct and indirect purchasers under the Sherman Act §1 and state law analogues, respectively, sought treble damages, attorneys’ fees, and injunctive relief.  This was the first federal trial in which price-fixing claims brought by both direct and indirect purchasers were tried to verdict before a single jury.  The Daily Journal named the win among its Top 20 Defense Results in California, and The Am Law Litigation Daily recognized the team with “Litigator of the Week” honors.
  • Scored a significant trial victory on behalf of private equity fund SIG Growth Equity Fund I, its managing agent Susquehanna Growth Equity, and two of its partners, defeating all fraud claims brought against them in the Delaware Court of Chancery. The case arose after private equity firm Great Hill Partners acquired Plimus, an e-commerce payment processing business, with SIG as the largest selling shareholder.  Great Hill later sued the SIG defendants and others for alleged fraud in connection with Plimus’ sale.  After the SIG defendants suffered multiple adverse decisions with prior counsel, Gibson Dunn was retained by Susquehanna International Group, the largest options trading platform in the world, to represent its private equity arm in Susquehanna’s most important litigation matter.

RECENT PUBLICATIONS

Who’s Who Legal 2021 Recognizes Eight Gibson Dunn Partners in Commercial Litigation

-October 19, 2021

Benchmark Litigation Names Four Gibson Dunn Partners Among its 2021 Top 100 Trial Lawyers

-October 7, 2021

Gibson Dunn Named Patent Litigation Firm of the Year by LMG Life Sciences

-September 23, 2021

Richard Doren and Veronica Moyé Named Litigators of the Week

-September 17, 2021

California Court of Appeal Confirms That Trial Courts Have the Authority to Strike PAGA Claims That Are Unmanageable

-September 15, 2021

Randy Mastro and Akiva Shapiro Named Litigators of the Week

-August 23, 2021

Ten Gibson Dunn Partners Named Among Benchmark Top 250 Women in Litigation 2021

-August 9, 2021

Theodore Boutrous, Samuel Liversidge and Rod Stone Named Litigators of the Week

-June 21, 2021

The Hollywood Reporter Names Theodore Boutrous, Scott Edelman, Kevin Masuda and Orin Snyder to its 2021 Power Lawyers List

-May 27, 2021

Scott Edelman Inducted Into the International Academy of Trial Lawyers

-April 5, 2021

Josh Krevitt and Stuart Rosenberg Named Litigators of the Week

-February 17, 2021

Three Gibson Dunn Cases Named Top Verdicts of the Year 2020

-February 16, 2021

Who’s Who Legal 2020 Litigation Recognizes Nine Gibson Dunn Partners

-December 7, 2020

Webcast: Antitrust Merger Trials – Lessons Learned and Strategies for Success

-November 10, 2020

Global Competition Review Recognizes Gibson Dunn for Two Matters of the Year

-November 10, 2020

Benchmark Litigation US 2021 Gives Top Marks to Gibson Dunn

-October 16, 2020

Hong Kong Case Update: The Court of Appeal Confirmed That Pre-Trial Discovery Against a Non-Party Witness for Use in a Foreign Court Is Not Permissible

-October 7, 2020

Theodore Boutrous, Marcellus McRae and Debra Wong Yang Named Among California’s Top 100 Lawyers

-September 17, 2020

Scott Edelman Named 2020 Top Litigator & Trial Lawyer in Los Angeles

-July 22, 2020

Gibson Dunn Named the 2020 New York Litigation Department of the Year

-July 7, 2020

Benchmark Litigation Asia-Pacific Top 100 Women in Litigation Recognizes Two Partners

-June 22, 2020

California Supreme Court Holds No Right to Jury Trial for Unfair-Competition or False-Advertising-Law Claims

-May 1, 2020

Jane Love Named a Health Care/Life Science Trailblazer

-April 1, 2020

Mitch Karlan, Lee Dunst and Nancy Hart Named Litigators of the Week

-March 13, 2020

Gibson Dunn Wins Three Awards at 2020 Benchmark Litigation US East Awards Ceremony

-February 28, 2020

David Battaglia Inducted Into the International Academy of Trial Lawyers

-February 26, 2020

Richard Parker Named Litigator of the Week

-February 14, 2020

Gibson Dunn Named “Litigation Department of the Year” and Partner Theodore J. Boutrous Jr. Named “Litigator of the Year Grand Prize Winner” by The American Lawyer

-January 2, 2020

Anne Champion and Randy Mastro Named Litigators of the Week

-October 1, 2019

Several Gibson Dunn Cases Named Top Verdicts of the Year

-February 20, 2019

Rachel Brass and Scott Edelman Named Litigators of the Week

-December 20, 2018

Gibson Dunn Wins Texas Regional Litigation Department of the Year

-December 5, 2018

Gibson Dunn Win Recognized at LMG Life Sciences Awards

-September 12, 2018

Two Gibson Dunn Cases Named Top Verdicts of the Year

-February 21, 2018

Michele Maryott and Theane Evangelis Named Litigators of the Week

-February 15, 2018

Randy Mastro Named Litigator of the Week

-September 29, 2017

Five Gibson Dunn Cases Named Top Verdicts of the Year

-February 15, 2017

Evidence

-April 20, 2016

Two Gibson Dunn Cases Named Top Verdicts of the Year

-February 26, 2013